Provided by Tiger Fintech (Singapore) Pte. Ltd.

NH HEALTH

14.140
0.000
Volume:- -
Turnover:- -
Market Cap:6.35B
PE:-69.03
High:14.140
Open:14.140
Low:14.140
Close:14.140
52wk High:14.140
52wk Low:14.140
Shares:449.00M
HK Float Shares:449.00M
Volume Ratio:3.00
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.205
ROE:4.36%
ROA:-2.47%
PB:1.94
PE(LYR):-69.03
PS:4.26

Loading ...

Company Profile

Company Name:
NH HEALTH
Exchange:
SEHK
Establishment Date:
2015
Employees:
1041
Office Location:
T1 Building,13th Floor,400 Jianger Road,Binjiang District,Hangzhou,Zhejiang Province,China
Website:
- -
Zip Code:
310052
Fax:
86 57 1864 30935
Introduction:
New Horizon Health Ltd is an investment holding company principally engaged in developing and commercializing innovative cancer screening products. The Company is primarily engaged in the research and development, clinical development, test operation and commercialization of screening products for colorectal cancer, gastric cancer, cervical cancer and others. The Company’s main products include home-based colorectal cancer screening tests ColoClear and Pupu Tube, stool-based self-conducted screening product for H. pylori UU Tube, and non-invasive urine-based home-use screening test for cervical cancer CerviClear. The Company mainly conducts its businesses in the domestic market.

Directors

Name
Position
YAO Na Xin
Chairman of the Board,Director,Chairman of the Nomination Committee,Audit Committee Member
CHEN Yi You
Executive Director,Member of the Remuneration and Assessment Committee
YU Dan Ke
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman
WANG Yang
Independent Director,Audit Committee Member

Shareholders

Name
Position
Choi Yiau Chong
CFO
LV Ning
CTO
LIANG Ying Xian
Corporate Secretary
CHEN Yi You
Chief Science Officer